Alto Neuroscience Inc. ANRO
Super Investor & Insider
1
Fondi che lo detengono
#1450
Rank consenso
1.4%
% dei portafogli
$373,460
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0% | Buy | 16,613 | $373,460 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Alto Neuroscience Inc. is a biotechnology company that focuses on developing precision therapeutics for psychiatric disorders. The company's primary objective is to utilize advanced neurobiological insights and digital tools to tailor treatments for conditions like depression, anxiety, and other mental health disorders…
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees68
TickerANRO
Statistics
Market Cap$761.9M
Revenue (TTM)$0
Net Income-$63.2M
Net Margin—
EPS$-2.19
P/E-9.82
P/S—
P/B2.83
EV/EBITDA-5.82
ROE-38.9%
Dividend Yield—
Price$21.73
Data: Twelve Data · Revenue = mcap / P/S